Clinical Trial Update: Post-Marketing Study to Assess Complication Rates of Oncology Patients With Ports and Peripheral IVs

View source ↗

Summary

A completed post-marketing study by C. R. Bard evaluating complication rates of ports and peripheral IVs in oncology patients. The results provide safety data o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: C. R. Bard | Conditions: PORTs/Peripheral IVs Complication Rates | Status: COMPLETED